KHK2823

· Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KHK2823, covering 2024-04-29 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]